89 related articles for article (PubMed ID: 12405948)
1. The assessment of proliferating cell nuclear antigen (PCNA) immunostaining in primary gastrointestinal lymphomas and its relationship to histological grade, S + G2 + M phase fraction (flow cytometric analysis) and prognosis. A. L. Woods, P. A. Hall, N. A. Shepherd, A. M. Hanby, N. H. Waseem, D. P. Lane & D. A. Levison. Histopathology 1991; 19; 21-27.
Levison DA
Histopathology; 2002 Sep; 41(3A):162-3, discussion 163-4. PubMed ID: 12405948
[No Abstract] [Full Text] [Related]
2. The assessment of proliferating cell nuclear antigen (PCNA) immunostaining in primary gastrointestinal lymphomas and its relationship to histological grade, S+G2+M phase fraction (flow cytometric analysis) and prognosis.
Woods AL; Hall PA; Shepherd NA; Hanby AM; Waseem NH; Lane DP; Levison DA
Histopathology; 1991 Jul; 19(1):21-7. PubMed ID: 1680784
[TBL] [Abstract][Full Text] [Related]
3. The assessment of proliferating cell nuclear antigen (PCNA)immunostaining in primary gastrointestinal lymphomas and its relationship to histological grade, S + G2 + M phase fraction (flow cytometric analysis) and prognosis.
Woods AL; Hall PA; Shepherd NA; Hanby AM; Waseem NH; Lane DP; Levison DA
Histopathology; 2002 Sep; 41(3A):165-71. PubMed ID: 12405950
[No Abstract] [Full Text] [Related]
4. Prognostic impact of DNA ploidy pattern, S-phase fraction (SPF), and proliferating cell nuclear antigen (PCNA) in patients with primary gastric lymphoma.
Belessi CJ; Parasi AS; Manioudaki HS; Laoutaris NP; Legakis NC; Peros GT; Androulakis GA
J Surg Oncol; 2003 Apr; 82(4):247-55. PubMed ID: 12672009
[TBL] [Abstract][Full Text] [Related]
5. Proliferative activity determined by DNA flow cytometry and proliferating cell nuclear antigen (PCNA) immunohistochemistry as a prognostic factor in prostatic carcinoma.
Visakorpi T
J Pathol; 1992 Sep; 168(1):7-13. PubMed ID: 1360498
[TBL] [Abstract][Full Text] [Related]
6. Relationship between VEGF and p53 expression and tumor cell proliferation in human gastrointestinal carcinomas.
Montero E; Abreu C; Tonino P
J Cancer Res Clin Oncol; 2008 Feb; 134(2):193-201. PubMed ID: 17636327
[TBL] [Abstract][Full Text] [Related]
7. Nucleolar organizer regions (NORs) staining and proliferating cell nuclear antigen (PCNA) immunostaining in mucosa-associated lymphoid tissue (MALT) gastric lymphomas.
Mikou P; Kanavaros P; Aninos D; Tzardi M; Karameris A; Gorgoulis B; Papadopoulos N; Lavergne A; Galian A
Pathol Res Pract; 1993 Nov; 189(9):1004-9. PubMed ID: 7905623
[TBL] [Abstract][Full Text] [Related]
8. Proliferating cell nuclear antigen (PCNA), immunostaining and flow cytometric DNA analysis of renal cell carcinoma.
Tanioka F; Hiroi M; Yamane T; Hara H
Zentralbl Pathol; 1993 Aug; 139(3):185-93. PubMed ID: 8105885
[TBL] [Abstract][Full Text] [Related]
9. [Primary gastrointestinal malignant lymphoma: clinicopathological and immunocytochemical analysis of 108 cases].
Liu TH
Zhonghua Yi Xue Za Zhi; 1987 Sep; 67(9):492-6. PubMed ID: 3127019
[No Abstract] [Full Text] [Related]
10. The proliferative fraction in lymph nodes: a comparison of proliferating cell nuclear antigen morphometry to flow cytometry.
Krauss JS; Pantazis CG; Chandler FW
Ann Clin Lab Sci; 1992; 22(3):189-96. PubMed ID: 1354428
[TBL] [Abstract][Full Text] [Related]
11. Proliferating-cell nuclear antigen immunocytochemistry in the evaluation of gastrointestinal smooth-muscle tumors.
Sbaschnig RJ; Cunningham RE; Sobin LH; O'Leary TJ
Mod Pathol; 1994 Sep; 7(7):780-3. PubMed ID: 7824513
[TBL] [Abstract][Full Text] [Related]
12. Proliferating cell nuclear antigen and S phase fraction in endometrial stromal sarcoma.
Schofield JB; Mansi J; Camplejohn RS; Lane DP; Fisher C
J Clin Pathol; 1992 Aug; 45(8):664-7. PubMed ID: 1357005
[TBL] [Abstract][Full Text] [Related]
13. Clinicopathologic features, cellular differentiation, PCNA and P53 expressions in gastrointestinal stromal tumors.
Can B; Sökmensüer C
Hepatogastroenterology; 2003 Dec; 50 Suppl 2():ccxliii-ccxlviii. PubMed ID: 15244191
[TBL] [Abstract][Full Text] [Related]
14. A comparison of proliferating cell nuclear antigen (PCNA) immunostaining, nucleolar organizer region (AgNOR) staining, and histological grading in gastrointestinal stromal tumours.
Yu CC; Fletcher CD; Newman PL; Goodlad JR; Burton JC; Levison DA
J Pathol; 1992 Feb; 166(2):147-52. PubMed ID: 1348532
[TBL] [Abstract][Full Text] [Related]
15. A comparison of proliferation markers and their prognostic value for women with endometrial carcinoma. Ki-67, proliferating cell nuclear antigen, and flow cytometric S-phase fraction.
Nordström B; Strang P; Bergström R; Nilsson S; Tribukait B
Cancer; 1996 Nov; 78(9):1942-51. PubMed ID: 8909315
[TBL] [Abstract][Full Text] [Related]
16. Highly aggressive behavior and poor prognosis of small-cell carcinoma in the alimentary tract: flow-cytometric analysis and immunohistochemical staining for the p53 protein and proliferating cell nuclear antigen.
Kimura H; Konishi K; Maeda K; Yabushita K; Tsuji M; Miwa A
Dig Surg; 1999; 16(2):152-7. PubMed ID: 10207243
[TBL] [Abstract][Full Text] [Related]
17. MIB-1, Ki67, and PCNA scores and DNA flow cytometry in intermediate grade malignant lymphomas.
Pich A; Ponti R; Valente G; Chiusa L; Geuna M; Novero D; Palestro G
J Clin Pathol; 1994 Jan; 47(1):18-22. PubMed ID: 7907607
[TBL] [Abstract][Full Text] [Related]
18. Lack of correlation between flow cytometric and immunohistologic proliferation measurements of tumors.
Linden MD; el-Naggar AK; Nathanson SD; Jacobson G; Zarbo RJ
Mod Pathol; 1996 Jun; 9(6):682-9. PubMed ID: 8782208
[TBL] [Abstract][Full Text] [Related]
19. Multiple lymphomatous polyposis of the gastrointestinal tract.
Isaacson PG; MacLennan KA; Subbuswamy SG
Histopathology; 1984 Jul; 8(4):641-56. PubMed ID: 6479906
[TBL] [Abstract][Full Text] [Related]
20. P 53 and PCNA in Non Hodgkin's lymphoma--an immunohistochemical evaluation.
Burra U; Shanthi P; Krishnan KB; Madhavan M
Indian J Pathol Microbiol; 2000 Jan; 43(1):61-4. PubMed ID: 12583422
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
